Cerca
Cerca
Edicola digitale
+

EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture

default_image

AdnKronos
  • a
  • a
  • a

Dai blog